An Open-label Study to Evaluate the Long-term Safety of MEDI-546, for the Treatment of SLE, in Adults
NCT01753193
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
218
Enrollment
INDUSTRY
Sponsor class
Conditions
Lupus Erythematosus, Systemic
Interventions
BIOLOGICAL:
Anifrolumab
Sponsor
MedImmune LLC